loading
Aspira Womens Health Inc stock is traded at $0.81, with a volume of 208.91K. It is up +6.58% in the last 24 hours and down -16.06% over the past month. Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
See More
Previous Close:
$0.76
Open:
$0.7592
24h Volume:
208.91K
Relative Volume:
2.20
Market Cap:
$13.17M
Revenue:
$9.15M
Net Income/Loss:
$-16.18M
P/E Ratio:
-0.2786
EPS:
-2.907
Net Cash Flow:
$-15.92M
1W Performance:
+10.96%
1M Performance:
-16.06%
6M Performance:
-64.63%
1Y Performance:
-75.68%
1-Day Range:
Value
$0.7592
$0.84
1-Week Range:
Value
$0.6694
$0.84
52-Week Range:
Value
$0.6679
$5.65

Aspira Womens Health Inc Stock (AWH) Company Profile

Name
Name
Aspira Womens Health Inc
Name
Phone
512-519-0400
Name
Address
12117 BEE CAVES ROAD BUILDING THREE, AUSTIN
Name
Employee
64
Name
Twitter
@ASPiRALabs
Name
Next Earnings Date
2024-12-13
Name
Latest SEC Filings
Name
AWH's Discussions on Twitter

Compare AWH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
AWH
Aspira Womens Health Inc
0.81 13.17M 9.15M -16.18M -15.92M -2.907
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
521.66 199.82B 42.37B 6.14B 7.78B 15.26
Diagnostics & Research icon
DHR
Danaher Corp
238.83 173.66B 23.74B 3.89B 4.98B 7.93
Diagnostics & Research icon
A
Agilent Technologies Inc
138.14 38.64B 6.51B 1.29B 1.37B 3.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
201.43 36.52B 15.32B 1.41B 1.96B 5.95
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
421.76 34.55B 3.84B 866.24M 792.60M 9.80

Aspira Womens Health Inc Stock (AWH) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-12-22 Resumed Cantor Fitzgerald Overweight
Mar-29-21 Initiated Truist Buy
Jan-29-21 Initiated Cantor Fitzgerald Overweight
Oct-30-20 Initiated William Blair Outperform

Aspira Womens Health Inc Stock (AWH) Latest News

pulisher
Nov 20, 2024

Aspira: Q3 Earnings Snapshot - New Haven Register

Nov 20, 2024
pulisher
Nov 19, 2024

Aspira Women's Health Inc. (AWH) reports earnings - Quartz

Nov 19, 2024
pulisher
Nov 19, 2024

Aspira Women's Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 19, 2024
pulisher
Nov 15, 2024

Aspira Women’s Health Inc. (NASDAQ:AWH) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... By GuruFocus - Investing.com Canada

Nov 15, 2024
pulisher
Nov 14, 2024

Aspira Women’s Health Reports Q3 2024 Growth and Strategic Advances - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Expands Stake in Aspira Womens Health Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Aspira Women’s Health reports Q3 revenue $2.3M, consensus $2.73M - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Aspira Women's Health Q3: OvaWatch Grows 27%, Secures $10M Federal Contract | AWH Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Aspira Women's Health Inc (AWH) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated by Analysts at StockNews.com - Defense World

Nov 13, 2024
pulisher
Nov 09, 2024

Aspira Women?s Health Expands Co-Marketing and Distribution Collaboration with BioReference to Include OvaWatch - Marketscreener.com

Nov 09, 2024
pulisher
Nov 07, 2024

Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Aspira Women's Health Expands BioReference Partnership, Reaches 15M+ Women With OvaWatch | AWH Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World

Nov 07, 2024
pulisher
Nov 04, 2024

Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 - StockTitan

Nov 04, 2024
pulisher
Nov 04, 2024

Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 - The Manila Times

Nov 04, 2024
pulisher
Nov 01, 2024

Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com - Defense World

Nov 01, 2024
pulisher
Oct 29, 2024

Aspira Women's Health updates product pipeline status By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

Aspira Women's Health updates product pipeline status - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Aspira Women’s Health Highlights Future Product Developments - TipRanks

Oct 29, 2024
pulisher
Oct 25, 2024

AWH Stock Plummets 6.19% Amid Weak Financial Performance - GuruFocus.com

Oct 25, 2024
pulisher
Oct 25, 2024

Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 - The Manila Times

Oct 25, 2024
pulisher
Oct 25, 2024

Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - The Manila Times

Oct 25, 2024
pulisher
Oct 25, 2024

Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 - StockTitan

Oct 25, 2024
pulisher
Oct 25, 2024

Aspira Women's Health secures $10M ARPA-H award - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Aspira Women's Health secures $10M ARPA-H award By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Aspira Women's Health's SWOT analysis: stock faces growth hurdles amid diagnostic advances By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

FACT SHEET: Biden-Harris Administration Announces $110 Million in Awards from ARPA-H's Sprint for Women's Health to Accelerate New Discoveries and Innovation - The American Presidency Project

Oct 24, 2024
pulisher
Oct 24, 2024

FemTech start-ups share in $110m Sprint for Women's Health - substack.com

Oct 24, 2024
pulisher
Oct 23, 2024

Aspira Women's Health's SWOT analysis: stock faces growth hurdles amid diagnostic advances - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

HLTH24: Jill Biden announces $110M ARPA-H funding award, prods industry to invest in women's health - Fierce healthcare

Oct 23, 2024
pulisher
Oct 23, 2024

Aspira Women's Health Inc. Announces Its Selection Receive $10 Million Award from Advanced Research Projects Agency for Health?s Sprint for Women's Health - Marketscreener.com

Oct 23, 2024
pulisher
Oct 23, 2024

Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health - The Manila Times

Oct 23, 2024
pulisher
Oct 23, 2024

Innovative Food Holdings, Inc. Announces Fulfillment of Largest Purchase Order in the Company's History - The Manila Times

Oct 23, 2024
pulisher
Oct 23, 2024

Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health - StockTitan

Oct 23, 2024
pulisher
Oct 23, 2024

First Lady Dr. Jill Biden Announces $110 Million in Awards for Women's Health Research Push - The Washington Informer

Oct 23, 2024
pulisher
Oct 19, 2024

Aspira Women's Health faces Nasdaq delisting over share price - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Aspira Women's Health faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa

Oct 18, 2024
pulisher
Oct 18, 2024

FDA's LDT RULE: Steps to Prepare for Your FDA 1st Milestone SubmissionDARKDaily.com - DARKDaily.com - Laboratory News

Oct 18, 2024
pulisher
Oct 16, 2024

Aspira Women’s Health gets approval for OvaWatch ovarian cancer test - Medical Device Network

Oct 16, 2024
pulisher
Oct 16, 2024

Aspira Women's Health Receives Approval from New York State Department of Health for OvaWatch® - The Manila Times

Oct 16, 2024
pulisher
Oct 15, 2024

Actelis Networks Announces Follow-On Order from U.S. Department of Transportation Agency Expanding Footprint to New Regions - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® - StockTitan

Oct 15, 2024
pulisher
Oct 14, 2024

StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV) - Defense World

Oct 14, 2024
pulisher
Oct 11, 2024

HOLX Launches BustTheMyth Campaign for Breast Health Awareness - Yahoo Finance

Oct 11, 2024
pulisher
Oct 08, 2024

Analysts’ New Coverage for October 8th (ABT, ACLX, ALIM, AWH, BCAX, BCS, BIG, BTDR, CARV, CHEK) - Defense World

Oct 08, 2024
pulisher
Oct 07, 2024

AWH Stock Plummets as Financial Data Reflects Losses - GuruFocus.com

Oct 07, 2024
pulisher
Oct 04, 2024

Aspira Womens Health (AWH) Shares Plunge Amid Financial Challenges - GuruFocus.com

Oct 04, 2024

Aspira Womens Health Inc Stock (AWH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Aspira Womens Health Inc Stock (AWH) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Cavanaugh Stefanie L.
Director
Sep 30 '24
Option Exercise
0.00
5,938
0
60,914
Parnell Winfred
Director
Sep 30 '24
Option Exercise
0.00
5,156
0
55,740
Herchuk Jannie Prestridge
Director
Sep 30 '24
Option Exercise
0.00
8,438
0
57,190
Ragard John Phillip
Director
Sep 30 '24
Option Exercise
0.00
4,844
0
120,203
Fralick Celeste Rachelle
Director
Sep 30 '24
Option Exercise
0.00
5,000
0
45,665
Sandford Nicole
Chief Executive Officer
May 31 '24
Buy
2.42
9,493
22,973
70,596
Merchant Minh Hoang
Secretary & General Counsel
Dec 06 '23
Sale
3.37
980
3,303
0
Sandford Nicole
President & CEO
Dec 06 '23
Buy
3.36
5,000
16,800
58,703
diagnostics_research LH
$242.15
price up icon 1.43%
$168.45
price up icon 0.08%
$144.36
price up icon 0.99%
diagnostics_research WAT
$386.57
price down icon 0.41%
diagnostics_research MTD
$1,243.40
price up icon 0.90%
$421.76
price up icon 1.06%
Cap:     |  Volume (24h):